The Valley Desk

NCT04104776 · Interventional trial

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Endometrial Cancer, Lymphoma, T-Cell, Mesothelioma, Malignant, Metastatic Castration-resistant Prostate Cancer, Ovarian Clear Cell Carcinoma, Prostatic Neoplasms, Castration-Resistant

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov